Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome
Study Details
Study Description
Brief Summary
To compare the safety and effectiveness of fluconazole and amphotericin B as maintenance treatment for preventing the relapse of cryptococcal meningitis in patients with AIDS.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Inclusion Criteria
Concurrent Medication:
Allowed:
-
Antivirals such as zidovudine.
-
Prophylaxis (including aerosolized pentamidine) for Pneumocystis carinii pneumonia (PCP).
-
Pfizer must be notified if the patient is receiving ganciclovir (DHPG) at entry.
Concurrent Treatment:
Allowed:
- Radiation therapy for mucocutaneous Kaposi's sarcoma.
Patients must be oriented to person, place, and time, and able to give written informed consent.
-
Patients must have had an acute episode of cryptococcal meningitis that was documented by recovery and identification of Cryptococcus neoformans from lumbar cerebrospinal fluid (CSF) culture within 6 months prior to entry.
-
Minimum total dose of 15 mg/kg of amphotericin B must have been given (either alone or in combination with flucytosine) during primary therapy.
-
Patients need not be receiving amphotericin B at the time of randomization but must begin study maintenance therapy within 6 weeks of completion of primary amphotericin B therapy. Patients may receive maintenance amphotericin B during the period between completion of primary therapy and study entry.
Prior Medication:
Allowed:
-
Antivirals such as zidovudine (AZT).
-
Prophylaxis (including aerosolized pentamidine) for Pneumocystis carinii pneumonia (PCP).
Exclusion Criteria
Co-existing Condition:
Patients with the following are excluded:
-
Clinical evidence of acute or chronic meningitis based upon any etiology other than cryptococcosis.
-
History of allergy or intolerance of imidazoles, azoles, or amphotericin B.
-
Moderate or severe liver disease.
Concurrent Medication:
Excluded:
-
Ketoconazole.
-
Fluconazole.
-
Itraconazole.
-
Miconazole.
-
Any systemic imidazole or azole for more than 7 days after initiation of primary therapy for cryptococcosis.
-
Intrathecal amphotericin B.
-
Coumarin-type anticoagulants.
-
Oral hypoglycemics.
-
Barbiturates.
-
Phenytoin.
-
Immunostimulants.
-
Investigational drugs or approved (licensed) drugs for investigational indications.
Concurrent Treatment:
Excluded:
- Lymphocyte replacement.
Patients with the following are excluded:
-
Clinical evidence of acute or chronic meningitis based upon any etiology other than cryptococcosis.
-
History of allergy or intolerance of imidazoles, azoles, or amphotericin B.
-
Moderate or severe liver disease.
-
Inability to take oral medications reliably.
Prior Medication:
Excluded:
-
Ketoconazole.
-
Fluconazole.
-
Itraconazole.
-
Miconazole.
-
Any systemic imidazole or azole for more than 7 days after initiation of primary therapy for cryptococcosis.
-
Intrathecal amphotericin B.
-
Coumarin-type anticoagulants.
-
Oral hypoglycemics.
-
Barbiturates.
-
Phenytoin.
-
Immunostimulants.
-
Investigational drugs or approved (licensed) drugs for investigational indications.
-
Any exceptions to these prohibitions of concomitant medications must be approved by Pfizer Central Research.
Prior Treatment:
Excluded:
- Lymphocyte replacement.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Univ of Alabama at Birmingham | Birmingham | Alabama | United States | 35294 |
2 | Tucson Veterans Administration Med Ctr | Tucson | Arizona | United States | 85724 |
3 | Dr Richard Meyer | Los Angeles | California | United States | 90048 |
4 | Davies Med Ctr | San Francisco | California | United States | 94114 |
5 | Dr Paul Rothman | Sherman Oaks | California | United States | 91403 |
6 | Wilmington Hosp / Med Ctr of Delaware | Wilmington | Delaware | United States | 19899 |
7 | George Washington Univ Med Ctr | Washington | District of Columbia | United States | 20037 |
8 | Univ of Florida College of Medicine | Gainesville | Florida | United States | 32610 |
9 | Univ of South Florida | Tampa | Florida | United States | 33612 |
10 | Emory Univ School of Medicine | Atlanta | Georgia | United States | 30303 |
11 | Med College of Georgia | Augusta | Georgia | United States | 30912 |
12 | DeKalb Gen Hosp | Decatur | Georgia | United States | 30033 |
13 | Shallowford Hosp | Decatur | Georgia | United States | 30033 |
14 | Northwestern Univ Med School | Chicago | Illinois | United States | 60611 |
15 | Dr Michael Bach | Portland | Maine | United States | 04102 |
16 | Univ of Maryland / Inst of Human Virology | Baltimore | Maryland | United States | 212011192 |
17 | New England Med Ctr | Boston | Massachusetts | United States | 02111 |
18 | Univ Hosp | Boston | Massachusetts | United States | 02118 |
19 | Ann Arbor Veterans Administration Med Ctr | Ann Arbor | Michigan | United States | 48105 |
20 | Harper Hosp | Detroit | Michigan | United States | 48201 |
21 | Henry Ford Hosp | Detroit | Michigan | United States | 48202 |
22 | Saint Michael's Med Ctr | Newark | New Jersey | United States | 07102 |
23 | Albany Med College / AIDS Treatment Ctr | Albany | New York | United States | 12203 |
24 | Jewish Hosp Ctr Affiliation | Jamaica | New York | United States | 11432 |
25 | Cabrini Med Ctr | New York | New York | United States | 10003 |
26 | Chelsea Village Med Ctr | New York | New York | United States | 10014 |
27 | Columbia Univ | New York | New York | United States | 10032 |
28 | Harlem AIDS Treatment Group / Harlem Hosp Ctr | New York | New York | United States | 10037 |
29 | Bowman Gray School of Medicine / North Carolina Baptist Hosp | Winston-Salem | North Carolina | United States | 27103 |
30 | Cincinnati Veterans Adm Med Ctr / Univ Hosp | Cincinnati | Ohio | United States | 452670405 |
31 | Buckley Braffman Stern Med Associates | Philadelphia | Pennsylvania | United States | 19107 |
32 | Univ TX Galveston Med Branch | Galveston | Texas | United States | 77550 |
33 | United States Air Force Med Ctr | Lackland Air Force Base | Texas | United States | 782365300 |
34 | Southwest Texas Methodist Hosp | San Antonio | Texas | United States | 78229 |
35 | Univ TX San Antonio Health Science Ctr | San Antonio | Texas | United States | 78284 |
36 | Richmond AIDS Consortium | Richmond | Virginia | United States | 23219 |
37 | CHG-118 Group Health / Cooperative of Puget Sound | Seattle | Washington | United States | 98112 |
38 | Dr Philip C Craven | Tacoma | Washington | United States | 98405 |
39 | Saint Michael's Hosp | Toronto | Ontario | Canada |
Sponsors and Collaborators
- Pfizer
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
- Powderly WG, Saag MS, Cloud GA, Robinson P, Meyer RD, Jacobson JM, Graybill JR, Sugar AM, McAuliffe VJ, Follansbee SE, et al. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group. N Engl J Med. 1992 Mar 19;326(12):793-8.
- Saag MS, Powderly WG, Cloud GA, Robinson P, Grieco MH, Sharkey PK, Thompson SE, Sugar AM, Tuazon CU, Fisher JF, et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med. 1992 Jan 9;326(2):83-9.
- 012D
- 056-157